These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 20659122)

  • 21. [Role of new biological therapy in psoriasis treatment].
    Cortijo Cascajares S; García Rodríguez MP; Campo Angora M; Serrano Garrote O; Herreros de Tejada A
    Farm Hosp; 2004; 28(3):192-200. PubMed ID: 15222873
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Psoriatic erythroderma treated with etanercept].
    Piqué-Duran E; Pérez-Cejudo JA
    Actas Dermosifiliogr; 2007 Sep; 98(7):508-10. PubMed ID: 17669311
    [No Abstract]   [Full Text] [Related]  

  • 23. Treatment of psoriasis. Part 2. Systemic therapies.
    Lebwohl M; Ali S
    J Am Acad Dermatol; 2001 Nov; 45(5):649-61; quiz 662-4. PubMed ID: 11606913
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Topical and systemic treatment of psoriasis: Part 2.
    Richards C
    Nurs Times; 1995 Jun 21-7; 91(25):38-9. PubMed ID: 7630757
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Systemic therapy of psoriasis].
    Altmeyer P; Nüchel C
    Dtsch Med Wochenschr; 1996 Dec; 121(51-52):1605-7. PubMed ID: 9011488
    [No Abstract]   [Full Text] [Related]  

  • 26. Methotrexate reduces incidence of vascular diseases in veterans with psoriasis or rheumatoid arthritis.
    Prodanovich S; Ma F; Taylor JR; Pezon C; Fasihi T; Kirsner RS
    J Am Acad Dermatol; 2005 Feb; 52(2):262-7. PubMed ID: 15692471
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Immunosuppresive agents, retinoids and new trends in the therapy of psoriasis].
    Svozil M
    Ceska Slov Farm; 2002 Nov; 51(6):267-72. PubMed ID: 12501485
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Immunosuppressive agents in the treatment of psoriasis].
    Ruszczak Z
    Vestn Dermatol Venerol; 1976 Jan; (1):35-40. PubMed ID: 997862
    [No Abstract]   [Full Text] [Related]  

  • 29. Increased arterial stiffness in patients with psoriasis is associated with active systemic inflammation.
    Yiu KH; Yeung CK; Chan HT; Wong RM; Tam S; Lam KF; Yan GH; Yue WS; Chan HH; Tse HF
    Br J Dermatol; 2011 Mar; 164(3):514-20. PubMed ID: 21039409
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Combined topical calcipotriene ointment 0.005% and various systemic therapies in the treatment of plaque-type psoriasis vulgaris: review of the literature and results of a survey sent to 100 dermatologists.
    Katz HI
    J Am Acad Dermatol; 1997 Sep; 37(3 Pt 2):S62-8. PubMed ID: 9344188
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Palmoplantar pustulosis with arthro-osteitis: successful treatment with etanercept and acitretin.
    Antoniou C; Nicolaidou E; Moustou AE; Stratigos A; Katsambas A
    J Eur Acad Dermatol Venereol; 2009 Jul; 23(7):854-5. PubMed ID: 19646137
    [No Abstract]   [Full Text] [Related]  

  • 32. Rifampicin--a mild immunosuppressive agent for psoriasis.
    Tsankov N; Grozdev I
    J Dermatolog Treat; 2011 Apr; 22(2):62-4. PubMed ID: 20653488
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Severe psoriasis: beyond the skin, what are the risks of not treating the disease?].
    Bessis D
    Ann Dermatol Venereol; 2008 Jul; 135 Suppl 5():S285-9. PubMed ID: 18721666
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Methotrexate and other chemotherapeutic agents used to treat psoriasis.
    Jeffes EW; Weinstein GD
    Dermatol Clin; 1995 Oct; 13(4):875-90. PubMed ID: 8785891
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inflammation in atherosclerosis and psoriasis: common pathogenic mechanisms and the potential for an integrated treatment approach.
    Späh F
    Br J Dermatol; 2008 Aug; 159 Suppl 2():10-7. PubMed ID: 18700910
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The potential of pharmacogenetics in optimizing the use of methotrexate for psoriasis.
    Warren RB; Griffiths CE
    Br J Dermatol; 2005 Nov; 153(5):869-73. PubMed ID: 16225593
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Experiences with an ambulatory immunosuppressive therapy of generalized psoriasis].
    Weitgasser H
    Hautarzt; 1972 Jul; 23(7):316-8. PubMed ID: 4632032
    [No Abstract]   [Full Text] [Related]  

  • 38. Epstein-Barr virus and human herpesvirus type 6 infection in patients with psoriasis.
    Neimann AL; Hodinka RL; Joshi YB; Elkan M; Van Voorhees AS; Gelfand JM
    Eur J Dermatol; 2006; 16(5):548-52. PubMed ID: 17101477
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Practical use of immunosuppressive drugs and cytostatics in dermatological diseases].
    Schuppli R
    Rev Clin Esp; 1970 Mar; 116(6):581-4. PubMed ID: 5517883
    [No Abstract]   [Full Text] [Related]  

  • 40. [A new view of psoriasis].
    Jullien D; Solignac M
    Ann Dermatol Venereol; 2010 Apr; 137(4 Suppl):3-7. PubMed ID: 20510168
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.